Snow
All India Institute of Speech and Hearing, Mysuru
(An Autonomous institute Under Ministry of Health and Family Welfare, Government of India.)

Library and Information Center

Amazon cover image
Image from Amazon.com

Biostatistics in clinical trials / editors, Carol K. Redmond, Theodore Colton.

Contributor(s): Material type: TextSeries: The Wiley reference series in biostatisticsPublication details: Chichester ; New York : Wiley, c2001.Description: xx, 501 p. : ill. ; 25 cmISBN:
  • 0471822116 (alk. paper)
Subject(s): DDC classification:
  • 615.507 24 RED C 21
LOC classification:
  • R853.S7 B49 2001
Online resources:
Contents:
Adaptive and Dynamic Methods of Treatment Assignment. Antibacterial Agent Trials. Audit and Quality Control. Bayesian Methods. Benefit/Risk Assessment. Binding or Masking. Clinical Significance Versus Statistical Significance. Clinical Trials, Overview. Cluster Randomization. Cochrane Collaboration. Community Intervention Trials. Compliance Assessment. CONSORT. Controlled Clinical Trials. Cooperative Cancer Trials. Cooperative Heart Disease Trials. Cooperative Studies Program, US Department of Veterans Affairs. Cost-effectiveness. Covariate Imbalance, Adjustment for. Crossover Designs. Data and Safety Monitoring. Data and Safety Monitoring Boards. Data Management and Coordination. Drug Approval and Regulation. Drug Interactions. Eligibility and Exclusion Criteria. Equivalence Trials. Ethics. European Federation of Statisticians in the Pharmaceutical Industry (EFPSI). European Organization for Research and Treatment of Cancer (EORTC). Factorial Designs. Fraud. Group-randomization Designs. Guidelines. Historical Controls, Bias From. History, Early Cancer and Heart Disease Trials. History, Overview. Intention-to-Treat Analysis. International Studies of Infarct Survival (ISIS). Medical Ethics and Statistics. Medical Research Council (MRC) Streptomycin Trial. Meta-analysis. Missing Data. Multicenter Trials. Multiple Endpoints. Multiplicity. Noncompliance, Adjustment for. Nonrandomized Trials. NSABP and Advances in the Treatment of Breast Cancer. Number Needed to Treat (NNT). Outcome Measures. Pharmaceutical Industry, Statistics in. Phase I Trials. Phase II Trials. Physicians' Health Study. Postmarketing Surveillance of New Drugs and Assessment of Risk. Preclinical Treatment Evaluation. Prevention Trials. Protocols. QUOROM. Randomization. Randomized Treatment Assignment. Salk Vaccine. Sample Size Determination. Screening Trials. Sequential Methods. Society for Clinical Trials. Software. Statistical Review for Medical Journals. Statistical Review for Medical Journals, Guidelines for Authors. Statisticians in the Pharmaceutical Industry (PSI). Surrogate Endpoints. Textbooks. Time-varying Treatment Effect. Treatment--Covariate Interaction. University Group Diabetes Program (UGDP). Vaccine Studies.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
Cover image Item type Current library Home library Collection Shelving location Call number Materials specified Vol info URL Copy number Status Notes Date due Barcode Item holds Item hold queue priority Course reserves
Reference text books All India Institute of Speech and Hearing R-29/2 615.507 24 RED C (Browse shelf) Available 17520
Reference text books All India Institute of Speech and Hearing R-29/2 615.507 24 RED C (Browse shelf) Available 12516
Total holds: 0

Includes bibliographical references and index.

Adaptive and Dynamic Methods of Treatment Assignment. Antibacterial Agent Trials. Audit and Quality Control. Bayesian Methods. Benefit/Risk Assessment. Binding or Masking. Clinical Significance Versus Statistical Significance. Clinical Trials, Overview. Cluster Randomization. Cochrane Collaboration. Community Intervention Trials. Compliance Assessment. CONSORT. Controlled Clinical Trials. Cooperative Cancer Trials. Cooperative Heart Disease Trials. Cooperative Studies Program, US Department of Veterans Affairs. Cost-effectiveness. Covariate Imbalance, Adjustment for. Crossover Designs. Data and Safety Monitoring. Data and Safety Monitoring Boards. Data Management and Coordination. Drug Approval and Regulation. Drug Interactions. Eligibility and Exclusion Criteria. Equivalence Trials. Ethics. European Federation of Statisticians in the Pharmaceutical Industry (EFPSI). European Organization for Research and Treatment of Cancer (EORTC). Factorial Designs. Fraud. Group-randomization Designs. Guidelines. Historical Controls, Bias From. History, Early Cancer and Heart Disease Trials. History, Overview. Intention-to-Treat Analysis. International Studies of Infarct Survival (ISIS). Medical Ethics and Statistics. Medical Research Council (MRC) Streptomycin Trial. Meta-analysis. Missing Data. Multicenter Trials. Multiple Endpoints. Multiplicity. Noncompliance, Adjustment for. Nonrandomized Trials. NSABP and Advances in the Treatment of Breast Cancer. Number Needed to Treat (NNT). Outcome Measures. Pharmaceutical Industry, Statistics in. Phase I Trials. Phase II Trials. Physicians' Health Study. Postmarketing Surveillance of New Drugs and Assessment of Risk. Preclinical Treatment Evaluation. Prevention Trials. Protocols. QUOROM. Randomization. Randomized Treatment Assignment. Salk Vaccine. Sample Size Determination. Screening Trials. Sequential Methods. Society for Clinical Trials. Software. Statistical Review for Medical Journals. Statistical Review for Medical Journals, Guidelines for Authors. Statisticians in the Pharmaceutical Industry (PSI). Surrogate Endpoints. Textbooks. Time-varying Treatment Effect. Treatment--Covariate Interaction. University Group Diabetes Program (UGDP). Vaccine Studies.

There are no comments on this title.

to post a comment.